Prognostic factors in patients with advanced cancer and COVID-19: a cohort from the Palliative Care Unit of the Brazilian National Cancer Institute
Objective To describe overall survival (OS) in 90 days and to evaluate the prognostic factors in patients with advanced cancer and COVID-19. Methods This is a retrospective cohort study carried out at the Palliative Care Unit of the Brazilian National Cancer Institute. Patients with advanced cancer...
Gespeichert in:
| Veröffentlicht in: | Supportive care in cancer 2021-10, Vol.29 (10), p.6005-6012 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 6012 |
|---|---|
| container_issue | 10 |
| container_start_page | 6005 |
| container_title | Supportive care in cancer |
| container_volume | 29 |
| creator | de Oliveira, Livia Costa da Costa Rosa, Karla Santos Borsatto, Alessandra Zanei de Oliveira, Luciana Aparecida Faria de Freitas, Renata dos Santos Machado Sampaio, Simone Garruth |
| description | Objective
To describe overall survival (OS) in 90 days and to evaluate the prognostic factors in patients with advanced cancer and COVID-19.
Methods
This is a retrospective cohort study carried out at the Palliative Care Unit of the Brazilian National Cancer Institute. Patients with advanced cancer and COVID-19 confirmed by Reverse Transcription Polymerase Chain Reaction were included. Kaplan-Meier’s curves, log-rank test, and Cox regression were performed.
Results
Eighty-three inpatients were selected. The average age was 61.4 (±12.6) years, with a higher proportion of women (73.4%). The most prevalent tumor type was breast (36.7%), followed by gastrointestinal tract (20.3%). The OS was 32 [interquartile range (IQR): 6–70] days, and at the end of the follow-up period, 17 patients (20.5%) were alive and 66 (79.5%) had died. Patients with advanced cancer and COVID-19 and who were 60–74 years old [hazard ratio (HR): 2.03; 95% confidence interval (CI): 1.09–3.78], with lung tumors (HR: 17.50; 95% CI: 1.70–28.34), with lung metastasis (HR: 4.21; 95% CI: 2.17–8.15), and with chronic obstructive pulmonary disease (HR: 4.92; 95% CI: 1.01–24.69) had higher risk of death in 90 days.
Conclusion
The age of 60–74 years old, lung tumors (primary or metastases), and the presence of chronic obstructive pulmonary disease were considered independent prognostic factors in patients with advanced cancer and COVID-19. |
| doi_str_mv | 10.1007/s00520-021-06149-1 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8005668</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A674054635</galeid><sourcerecordid>A674054635</sourcerecordid><originalsourceid>FETCH-LOGICAL-c541t-57713bce0cbd0efefc87901a2309415325eee3d4f294dcd9f6469899bdfa1ac3</originalsourceid><addsrcrecordid>eNp9ks1u1DAUhSMEotPCC7BAltiwSbFjO4lZIJUpPyNVtIvC1vI41zOuEntqO4PgNXhhnJkyUISQF1fy_e7xPdYpimcEnxKMm1cRY17hElekxDVhoiQPihlhlJYNpeJhMcOCkZJRzo-K4xhvMCZNw6vHxRGlTSNaTGbFj6vgV87HZDUySicfIrIObVSy4FJEX21aI9VtldPQIT2VgJTr0Pzyy-K8JOI1Ukj7tQ8JmeAHlNaArlTf26ywBTRXAdBnZxPyZtd7G9R3m7sOfcqEd6rPzE514fIWaUzwpHhkVB_h6V09Ka7fv7uefywvLj8s5mcXpeaMpJI3DaFLDVgvOwwGjG4bgYmq6OSb04oDAO2YqQTrdCdMzWrRCrHsjCJK05PizV52My4H6HT2G1QvN8EOKnyTXll5v-PsWq78Vrb53-u6zQIv7wSCvx0hJjnYqKHvlQM_RllxXHMiGK0y-uIv9MaPIZufqLoluGbZzIFaqR6kdcbnd_UkKs_qhmHOasozdfoPKp8OBqu9A2Pz_b2Baj-gg48xgDl4JFhOSZL7JMmcJLlLkpx2ef7n7xxGfkUnA3QPxNxyKwi_Lf1H9idT7NQY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2568106471</pqid></control><display><type>article</type><title>Prognostic factors in patients with advanced cancer and COVID-19: a cohort from the Palliative Care Unit of the Brazilian National Cancer Institute</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>de Oliveira, Livia Costa ; da Costa Rosa, Karla Santos ; Borsatto, Alessandra Zanei ; de Oliveira, Luciana Aparecida Faria ; de Freitas, Renata ; dos Santos Machado Sampaio, Simone Garruth</creator><creatorcontrib>de Oliveira, Livia Costa ; da Costa Rosa, Karla Santos ; Borsatto, Alessandra Zanei ; de Oliveira, Luciana Aparecida Faria ; de Freitas, Renata ; dos Santos Machado Sampaio, Simone Garruth</creatorcontrib><description>Objective
To describe overall survival (OS) in 90 days and to evaluate the prognostic factors in patients with advanced cancer and COVID-19.
Methods
This is a retrospective cohort study carried out at the Palliative Care Unit of the Brazilian National Cancer Institute. Patients with advanced cancer and COVID-19 confirmed by Reverse Transcription Polymerase Chain Reaction were included. Kaplan-Meier’s curves, log-rank test, and Cox regression were performed.
Results
Eighty-three inpatients were selected. The average age was 61.4 (±12.6) years, with a higher proportion of women (73.4%). The most prevalent tumor type was breast (36.7%), followed by gastrointestinal tract (20.3%). The OS was 32 [interquartile range (IQR): 6–70] days, and at the end of the follow-up period, 17 patients (20.5%) were alive and 66 (79.5%) had died. Patients with advanced cancer and COVID-19 and who were 60–74 years old [hazard ratio (HR): 2.03; 95% confidence interval (CI): 1.09–3.78], with lung tumors (HR: 17.50; 95% CI: 1.70–28.34), with lung metastasis (HR: 4.21; 95% CI: 2.17–8.15), and with chronic obstructive pulmonary disease (HR: 4.92; 95% CI: 1.01–24.69) had higher risk of death in 90 days.
Conclusion
The age of 60–74 years old, lung tumors (primary or metastases), and the presence of chronic obstructive pulmonary disease were considered independent prognostic factors in patients with advanced cancer and COVID-19.</description><identifier>ISSN: 0941-4355</identifier><identifier>EISSN: 1433-7339</identifier><identifier>DOI: 10.1007/s00520-021-06149-1</identifier><identifier>PMID: 33779801</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Aged ; Cancer ; Cancer patients ; Care and treatment ; Chronic obstructive pulmonary disease ; Cohort Studies ; Complications and side effects ; Coronaviruses ; COVID-19 ; Female ; Health risks ; Hospital patients ; Humans ; Lung cancer ; Lung Neoplasms ; Medical prognosis ; Medicine ; Medicine & Public Health ; Metastasis ; Middle Aged ; National Cancer Institute (U.S.) ; Nursing ; Nursing Research ; Oncology ; Oncology, Experimental ; Original ; Original Article ; Pain Medicine ; Palliative Care ; Palliative treatment ; Prognosis ; Rehabilitation Medicine ; Retrospective Studies ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Tumors ; United States</subject><ispartof>Supportive care in cancer, 2021-10, Vol.29 (10), p.6005-6012</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><rights>COPYRIGHT 2021 Springer</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c541t-57713bce0cbd0efefc87901a2309415325eee3d4f294dcd9f6469899bdfa1ac3</citedby><cites>FETCH-LOGICAL-c541t-57713bce0cbd0efefc87901a2309415325eee3d4f294dcd9f6469899bdfa1ac3</cites><orcidid>0000-0002-5052-1846</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00520-021-06149-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00520-021-06149-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,778,782,883,27907,27908,41471,42540,51302</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33779801$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Oliveira, Livia Costa</creatorcontrib><creatorcontrib>da Costa Rosa, Karla Santos</creatorcontrib><creatorcontrib>Borsatto, Alessandra Zanei</creatorcontrib><creatorcontrib>de Oliveira, Luciana Aparecida Faria</creatorcontrib><creatorcontrib>de Freitas, Renata</creatorcontrib><creatorcontrib>dos Santos Machado Sampaio, Simone Garruth</creatorcontrib><title>Prognostic factors in patients with advanced cancer and COVID-19: a cohort from the Palliative Care Unit of the Brazilian National Cancer Institute</title><title>Supportive care in cancer</title><addtitle>Support Care Cancer</addtitle><addtitle>Support Care Cancer</addtitle><description>Objective
To describe overall survival (OS) in 90 days and to evaluate the prognostic factors in patients with advanced cancer and COVID-19.
Methods
This is a retrospective cohort study carried out at the Palliative Care Unit of the Brazilian National Cancer Institute. Patients with advanced cancer and COVID-19 confirmed by Reverse Transcription Polymerase Chain Reaction were included. Kaplan-Meier’s curves, log-rank test, and Cox regression were performed.
Results
Eighty-three inpatients were selected. The average age was 61.4 (±12.6) years, with a higher proportion of women (73.4%). The most prevalent tumor type was breast (36.7%), followed by gastrointestinal tract (20.3%). The OS was 32 [interquartile range (IQR): 6–70] days, and at the end of the follow-up period, 17 patients (20.5%) were alive and 66 (79.5%) had died. Patients with advanced cancer and COVID-19 and who were 60–74 years old [hazard ratio (HR): 2.03; 95% confidence interval (CI): 1.09–3.78], with lung tumors (HR: 17.50; 95% CI: 1.70–28.34), with lung metastasis (HR: 4.21; 95% CI: 2.17–8.15), and with chronic obstructive pulmonary disease (HR: 4.92; 95% CI: 1.01–24.69) had higher risk of death in 90 days.
Conclusion
The age of 60–74 years old, lung tumors (primary or metastases), and the presence of chronic obstructive pulmonary disease were considered independent prognostic factors in patients with advanced cancer and COVID-19.</description><subject>Aged</subject><subject>Cancer</subject><subject>Cancer patients</subject><subject>Care and treatment</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Cohort Studies</subject><subject>Complications and side effects</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Female</subject><subject>Health risks</subject><subject>Hospital patients</subject><subject>Humans</subject><subject>Lung cancer</subject><subject>Lung Neoplasms</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>National Cancer Institute (U.S.)</subject><subject>Nursing</subject><subject>Nursing Research</subject><subject>Oncology</subject><subject>Oncology, Experimental</subject><subject>Original</subject><subject>Original Article</subject><subject>Pain Medicine</subject><subject>Palliative Care</subject><subject>Palliative treatment</subject><subject>Prognosis</subject><subject>Rehabilitation Medicine</subject><subject>Retrospective Studies</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Tumors</subject><subject>United States</subject><issn>0941-4355</issn><issn>1433-7339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9ks1u1DAUhSMEotPCC7BAltiwSbFjO4lZIJUpPyNVtIvC1vI41zOuEntqO4PgNXhhnJkyUISQF1fy_e7xPdYpimcEnxKMm1cRY17hElekxDVhoiQPihlhlJYNpeJhMcOCkZJRzo-K4xhvMCZNw6vHxRGlTSNaTGbFj6vgV87HZDUySicfIrIObVSy4FJEX21aI9VtldPQIT2VgJTr0Pzyy-K8JOI1Ukj7tQ8JmeAHlNaArlTf26ywBTRXAdBnZxPyZtd7G9R3m7sOfcqEd6rPzE514fIWaUzwpHhkVB_h6V09Ka7fv7uefywvLj8s5mcXpeaMpJI3DaFLDVgvOwwGjG4bgYmq6OSb04oDAO2YqQTrdCdMzWrRCrHsjCJK05PizV52My4H6HT2G1QvN8EOKnyTXll5v-PsWq78Vrb53-u6zQIv7wSCvx0hJjnYqKHvlQM_RllxXHMiGK0y-uIv9MaPIZufqLoluGbZzIFaqR6kdcbnd_UkKs_qhmHOasozdfoPKp8OBqu9A2Pz_b2Baj-gg48xgDl4JFhOSZL7JMmcJLlLkpx2ef7n7xxGfkUnA3QPxNxyKwi_Lf1H9idT7NQY</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>de Oliveira, Livia Costa</creator><creator>da Costa Rosa, Karla Santos</creator><creator>Borsatto, Alessandra Zanei</creator><creator>de Oliveira, Luciana Aparecida Faria</creator><creator>de Freitas, Renata</creator><creator>dos Santos Machado Sampaio, Simone Garruth</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88J</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2R</scope><scope>M2S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5052-1846</orcidid></search><sort><creationdate>20211001</creationdate><title>Prognostic factors in patients with advanced cancer and COVID-19: a cohort from the Palliative Care Unit of the Brazilian National Cancer Institute</title><author>de Oliveira, Livia Costa ; da Costa Rosa, Karla Santos ; Borsatto, Alessandra Zanei ; de Oliveira, Luciana Aparecida Faria ; de Freitas, Renata ; dos Santos Machado Sampaio, Simone Garruth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c541t-57713bce0cbd0efefc87901a2309415325eee3d4f294dcd9f6469899bdfa1ac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Cancer</topic><topic>Cancer patients</topic><topic>Care and treatment</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Cohort Studies</topic><topic>Complications and side effects</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Female</topic><topic>Health risks</topic><topic>Hospital patients</topic><topic>Humans</topic><topic>Lung cancer</topic><topic>Lung Neoplasms</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>National Cancer Institute (U.S.)</topic><topic>Nursing</topic><topic>Nursing Research</topic><topic>Oncology</topic><topic>Oncology, Experimental</topic><topic>Original</topic><topic>Original Article</topic><topic>Pain Medicine</topic><topic>Palliative Care</topic><topic>Palliative treatment</topic><topic>Prognosis</topic><topic>Rehabilitation Medicine</topic><topic>Retrospective Studies</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Tumors</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Oliveira, Livia Costa</creatorcontrib><creatorcontrib>da Costa Rosa, Karla Santos</creatorcontrib><creatorcontrib>Borsatto, Alessandra Zanei</creatorcontrib><creatorcontrib>de Oliveira, Luciana Aparecida Faria</creatorcontrib><creatorcontrib>de Freitas, Renata</creatorcontrib><creatorcontrib>dos Santos Machado Sampaio, Simone Garruth</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Sociology Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Social Science Database</collection><collection>Sociology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Supportive care in cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Oliveira, Livia Costa</au><au>da Costa Rosa, Karla Santos</au><au>Borsatto, Alessandra Zanei</au><au>de Oliveira, Luciana Aparecida Faria</au><au>de Freitas, Renata</au><au>dos Santos Machado Sampaio, Simone Garruth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic factors in patients with advanced cancer and COVID-19: a cohort from the Palliative Care Unit of the Brazilian National Cancer Institute</atitle><jtitle>Supportive care in cancer</jtitle><stitle>Support Care Cancer</stitle><addtitle>Support Care Cancer</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>29</volume><issue>10</issue><spage>6005</spage><epage>6012</epage><pages>6005-6012</pages><issn>0941-4355</issn><eissn>1433-7339</eissn><abstract>Objective
To describe overall survival (OS) in 90 days and to evaluate the prognostic factors in patients with advanced cancer and COVID-19.
Methods
This is a retrospective cohort study carried out at the Palliative Care Unit of the Brazilian National Cancer Institute. Patients with advanced cancer and COVID-19 confirmed by Reverse Transcription Polymerase Chain Reaction were included. Kaplan-Meier’s curves, log-rank test, and Cox regression were performed.
Results
Eighty-three inpatients were selected. The average age was 61.4 (±12.6) years, with a higher proportion of women (73.4%). The most prevalent tumor type was breast (36.7%), followed by gastrointestinal tract (20.3%). The OS was 32 [interquartile range (IQR): 6–70] days, and at the end of the follow-up period, 17 patients (20.5%) were alive and 66 (79.5%) had died. Patients with advanced cancer and COVID-19 and who were 60–74 years old [hazard ratio (HR): 2.03; 95% confidence interval (CI): 1.09–3.78], with lung tumors (HR: 17.50; 95% CI: 1.70–28.34), with lung metastasis (HR: 4.21; 95% CI: 2.17–8.15), and with chronic obstructive pulmonary disease (HR: 4.92; 95% CI: 1.01–24.69) had higher risk of death in 90 days.
Conclusion
The age of 60–74 years old, lung tumors (primary or metastases), and the presence of chronic obstructive pulmonary disease were considered independent prognostic factors in patients with advanced cancer and COVID-19.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>33779801</pmid><doi>10.1007/s00520-021-06149-1</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-5052-1846</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0941-4355 |
| ispartof | Supportive care in cancer, 2021-10, Vol.29 (10), p.6005-6012 |
| issn | 0941-4355 1433-7339 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8005668 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Aged Cancer Cancer patients Care and treatment Chronic obstructive pulmonary disease Cohort Studies Complications and side effects Coronaviruses COVID-19 Female Health risks Hospital patients Humans Lung cancer Lung Neoplasms Medical prognosis Medicine Medicine & Public Health Metastasis Middle Aged National Cancer Institute (U.S.) Nursing Nursing Research Oncology Oncology, Experimental Original Original Article Pain Medicine Palliative Care Palliative treatment Prognosis Rehabilitation Medicine Retrospective Studies SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Tumors United States |
| title | Prognostic factors in patients with advanced cancer and COVID-19: a cohort from the Palliative Care Unit of the Brazilian National Cancer Institute |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T18%3A47%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20factors%20in%20patients%20with%20advanced%20cancer%20and%20COVID-19:%20a%20cohort%20from%20the%20Palliative%20Care%20Unit%20of%20the%20Brazilian%20National%20Cancer%20Institute&rft.jtitle=Supportive%20care%20in%20cancer&rft.au=de%20Oliveira,%20Livia%20Costa&rft.date=2021-10-01&rft.volume=29&rft.issue=10&rft.spage=6005&rft.epage=6012&rft.pages=6005-6012&rft.issn=0941-4355&rft.eissn=1433-7339&rft_id=info:doi/10.1007/s00520-021-06149-1&rft_dat=%3Cgale_pubme%3EA674054635%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2568106471&rft_id=info:pmid/33779801&rft_galeid=A674054635&rfr_iscdi=true |